SLAM
TARO

Swiss Life Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Swiss Life Asset Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,399
Closed -$269K – 526
2017
Q2 		$269K Buy
2,399
+126
+6% +$14.2K 0.01% 440
2017
Q1 		$265K Sell
2,273
-2,271
-50% -$251K 0.01% 438
2016
Q4 		$478K Buy
4,544
+821
+22% +$86K 0.02% 369
2016
Q3 		$411K Buy
+3,723
New +$493K 0.01% 389

Other funds holding TARO

MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Swiss Life Asset Management's TARO Position: Q3 2017 in Review

Swiss Life Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2017, closing a stake of 2,399 shares — an estimated $269K sold.

Swiss Life Asset Management first reported a position in TARO in Q3 2016 and held it in 4 quarters. The position peaked at $478K in Q4 2016. 133 funds tracked by Wall St. Rank hold TARO as of Q3 2017.

  • Swiss Life Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2017 after selling out during the quarter.
  • Swiss Life Asset Management sold 2,399 Taro Pharmaceutical Industries Ltd. shares in Q3 2017, an estimated $269K.
  • Swiss Life Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2016 and held it in 4 quarters.
  • Swiss Life Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $478K in Q4 2016.
  • 133 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2017.

Based on Swiss Life Asset Management's 13F filing for Q3 2017, filed 29 Dec 2025.